HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaodong Cheng Selected Research

Aroclors

1/2018Oleanolic acid attenuates PCBs-induced adiposity and insulin resistance via HNF1b-mediated regulation of redox and PPARĪ³ signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaodong Cheng Research Topics

Disease

53Neoplasms (Cancer)
05/2022 - 07/2004
18Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 02/2007
15Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2022 - 02/2012
10Carcinogenesis
05/2022 - 01/2007
9Neoplasm Metastasis (Metastasis)
03/2021 - 01/2013
9Inflammation (Inflammations)
04/2020 - 01/2007
8Infections
04/2020 - 06/2013
7Ovarian Epithelial Carcinoma
01/2022 - 03/2006
6Carcinoma (Carcinomatosis)
05/2022 - 02/2007
5Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2021 - 04/2007
5Breast Neoplasms (Breast Cancer)
01/2018 - 01/2005
4Mental Disorders (Mental Disorder)
01/2020 - 01/2013
4Pancreatic Neoplasms (Pancreatic Cancer)
07/2017 - 01/2013
4Adenocarcinoma
10/2016 - 05/2013
3Melanoma (Melanoma, Malignant)
02/2022 - 07/2013
3Mitochondrial Diseases (Mitochondrial Disease)
11/2021 - 02/2016
3Pain (Aches)
11/2021 - 03/2016
3COVID-19
02/2021 - 08/2020
3Obesity
01/2018 - 02/2014
3Heart Failure
12/2017 - 05/2014
3Nervous System Diseases (Neurological Disorders)
12/2017 - 05/2014
2Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational)
04/2022 - 03/2019
2Lymphatic Metastasis
02/2022 - 01/2021
2Endometrial Neoplasms (Endometrial Cancer)
01/2022 - 01/2021
2Hyperthermia
01/2022 - 07/2021
2Hypoalbuminemia
01/2022 - 09/2021
2Femoral Neck Fractures
01/2022 - 08/2021
2Necrosis
11/2021 - 01/2021
2Chemical and Drug Induced Liver Injury
11/2021 - 01/2021
2Acute Promyelocytic Leukemia
07/2021 - 07/2012
2Uterine Cervical Dysplasia
01/2021 - 01/2016
2Demyelinating Diseases (Demyelinating Disease)
01/2021 - 01/2021
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2020 - 01/2016
2Vascular Remodeling
12/2020 - 11/2016
2Coronavirus Infections
11/2020 - 08/2020
2Prostatic Neoplasms (Prostate Cancer)
06/2020 - 02/2014
2Chronic Pain
01/2020 - 03/2016

Drug/Important Bio-Agent (IBA)

31Proteins (Proteins, Gene)FDA Link
05/2022 - 12/2002
19erythromycin propionate-N-acetylcysteinateIBA
11/2021 - 12/2007
13Pharmaceutical PreparationsIBA
11/2021 - 10/2005
7Biological ProductsIBA
01/2022 - 01/2014
7DNA (Deoxyribonucleic Acid)IBA
01/2022 - 02/2014
7Transcription Factors (Transcription Factor)IBA
01/2019 - 01/2005
6Messenger RNA (mRNA)IBA
05/2022 - 07/2007
6Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2014
5ElementsIBA
06/2022 - 04/2015
5RNA (Ribonucleic Acid)IBA
05/2022 - 12/2018
5Polysaccharides (Glycans)IBA
02/2022 - 01/2019
53- (5- tert- butylisoxazol- 3- yl)- 2- ((3- chlorophenyl)hydrazono)- 3- oxopropionitrileIBA
05/2018 - 11/2013
5Small Interfering RNA (siRNA)IBA
01/2014 - 02/2007
4AntigensIBA
02/2022 - 01/2014
4MethyltransferasesIBA
01/2022 - 02/2014
4Oncogene Proteins (Oncogene Protein)IBA
07/2021 - 08/2010
4Peptides (Polypeptides)IBA
03/2021 - 01/2007
4Glucose (Dextrose)FDA LinkGeneric
01/2021 - 05/2013
4Protein Isoforms (Isoforms)IBA
12/2020 - 08/2008
4Paclitaxel (Taxol)FDA LinkGeneric
10/2019 - 01/2014
3Circular RNAIBA
01/2022 - 10/2019
3Carrier Proteins (Binding Protein)IBA
01/2022 - 03/2006
3ArsenicIBA
09/2021 - 07/2012
3Therapeutic UsesIBA
09/2021 - 01/2019
3LipidsIBA
01/2021 - 01/2018
3MicroRNAs (MicroRNA)IBA
01/2021 - 01/2014
3Cyclic AMP (AMP, Cyclic)IBA
01/2020 - 07/2016
3Adenosine Monophosphate (AMP)IBA
01/2020 - 05/2014
3AntioxidantsIBA
08/2018 - 07/2004
3EnzymesIBA
01/2018 - 11/2007
3LithiumIBA
07/2017 - 01/2013
2Methotrexate (Mexate)FDA LinkGeneric
04/2022 - 01/2022
2Indicators and Reagents (Reagents)IBA
03/2022 - 10/2019
2CytosineIBA
02/2022 - 10/2014
2Cisplatin (Platino)FDA LinkGeneric
02/2022 - 08/2018
2Histones (Histone)IBA
01/2022 - 01/2018
2Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2022 - 09/2021
2CateninsIBA
01/2022 - 07/2016
2SYTOX GreenIBA
11/2021 - 01/2021
2Diclofenac (SR 38)FDA LinkGeneric
11/2021 - 01/2021
2Caspase 3 (Caspase-3)IBA
11/2021 - 01/2021
2CytokinesIBA
10/2021 - 02/2014
2Azacitidine (5 Azacytidine)FDA Link
10/2021 - 02/2014
2DecitabineFDA Link
10/2021 - 02/2014
2Anti-Bacterial Agents (Antibiotics)IBA
10/2021 - 04/2020
2TitaniumIBA
08/2021 - 01/2020
2MagnesiumIBA
08/2021 - 01/2020
2AlloysIBA
08/2021 - 01/2020
2UbiquitinIBA
07/2021 - 01/2013
2Long Noncoding RNAIBA
03/2021 - 12/2020
2Antiviral Agents (Antivirals)IBA
02/2021 - 01/2021
2oxidized low density lipoproteinIBA
01/2021 - 12/2020
2VaccinesIBA
11/2020 - 08/2020
2Methamphetamine (Desoxyn)FDA LinkGeneric
01/2020 - 01/2018
2ChromatinIBA
01/2020 - 01/2011
2Drug CombinationsIBA
03/2019 - 08/2018
2Arginine (L-Arginine)FDA Link
01/2019 - 01/2018

Therapy/Procedure

15Therapeutics
01/2022 - 01/2014
9Drug Therapy (Chemotherapy)
04/2022 - 01/2013
4Neoadjuvant Therapy
01/2020 - 10/2012
2Operative Time
04/2022 - 01/2022
2Length of Stay
04/2022 - 01/2022
2Ligation
01/2020 - 11/2016